NR1H4 and metabolic disease: Consistent with its important metabolic functions, disruptionof the FXR gene in transgenic mice was associated with metabolic diseases,including hypercholesterolemia, cholesterol gallstone disease, fatty liver, andtype 2 diabetes [46-49].